Revenue at constant currency rates: Revenue translated into the presentation currency, EUR, using the weighted average EUR currency exchange rate from the prior period. This measure provides additional transparency on revenue trends by excluding the impact of fluctuations in exchange rates.
Revenue not associated with the coronavirus pandemic: This measure provides additional transparency on revenue trends by excluding revenue associated with the coronavirus pandemic.
Gross margin: Gross profit as a percentage of revenue.
Operating result (EBIT): Earnings before total financial result and income tax charge.
EBITDA: Operating result (EBIT) plus depreciation, amortization and impairment charges (if any).
EBITDA Margin: EBITDA as a percentage of revenue.
Capital expenditures (Capex): Investments in property, plant and equipment assets and intangible assets capitalized during a reporting period.
Net operating assets: The sum of Non-current assets plus Current assets less Cash and cash equivalents less Current liabilities.
Return on net operating assets (RONOA): Last twelve months Operating result in percent of average Net operating assets.
Equity ratio: Equity at the end of the period divided by Total assets at the end of the period.
Free Cash Flow (FCF): Net cash flows from operating activities less cash paid for acquisition of intangible assets less cash paid for acquisition of property, plant and equipment assets.
Net Cash: Cash and cash equivalents less interest-bearing loans and borrowings less lease liabilities less other financial liabilities.
Headcount: Number of people employed by PolyPeptide at the time indicated (i.e. excluding contractors).